Around £45 billion in NHS funding will be diverted from other NHS care by 2036 to pay more for new medicines under the UK-U.S. trade deal agreed last December unless more funding is made available to cover the additional costs, suggests an analysis published by The BMJ .
UK-US trade deal will mean the NHS has to divert billions from other services to pay more for new medicines
Based on information published by MedicalXpress — Pharmaceutical News (linked below the article). How we report
Important: this content is for informational purposes only and is not medical advice, a prescribing instruction, or a recommendation to act. Consult a licensed healthcare professional before taking any medication.
